Alejandra Galván-De Los Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alejandra Galván-De Los Santos has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Camacho-Morales
Department of Biochemistry and Molecular Medicine, College of Medicine, Universidad Autónoma de Nuevo León, Mexico
1 shared publication - Annia López-Díaz
Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
1 shared publication - Augusto Rojas-Martinez
Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico
1 shared publication - César López-Camarillo
Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City 03100, Mexico
1 shared publication - Erika Margarita Carrillo-Casas
Department of Molecular Biology and Histocompatibility, General Hospital “Dr. Manuel Gea González
1 shared publication - Felipe Hernández Aguilar
Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
1 shared publication
Latest Publications
- 31 July 2015
- Published by SAGE Publications in Stem Cells and Development
- Vol. 24 (21) , 2577-2590
Differential Expression of Adhesion-Related Proteins and MAPK Pathways Lead to Suitable Osteoblast Differentiation of Human Mesenchymal Stem Cells Subpopulations
Cellular adhesion enables communication between cells and their environment. Adhesion can be achieved throughout focal adhesions and its components influence osteoblast differentiation of human mesenchymal stem cells (hMSCs). Because cell adhesion and osteoblast differentiation are closely related, this article aimed to analyze the expression profiles of adhesion-related proteins during osteoblastic differentiation of two hMSCs subpopulations (CD105 + and CD105 − ) and propose a strategy for assembling bone grafts based on its adhesion ability. In vitro experiments of osteogenic differentiation in CD105 − cells showed superior adhesion efficiency and 2-fold increase of α-actinin expression compared with CD105 + cells at the maturation stage. Interestingly, levels of activated β1-integrin increased in CD105 − cells during the process. Additionally, the CD105 − subpopulation showed 3-fold increase of phosphorylated FAK Y397 compared to CD105 + cells. Results also indicate that ERK1/2 was activated during CD105 − bone differentiation and participation of mitogen-activated protein kinase (MAPK)-p38 in CD105 + differentiation through a focal adhesion kinase (FAK)-independent pathway. In vivo trial demonstrated that grafts containing CD105 − showed osteocytes embedded in a mineralized matrix, promoted adequate graft integration, increased host vascular infiltration, and efficient intramembranous repairing. In contrast, grafts containing CD105 + showed deficient endochondral ossification and fibrocartilaginous tissue. Based on the expression of α-actinin, FAKy, 397 and ERK1/2 activation, we define maturation stage as critical for bone graft assembling. By in vitro assays, CD105 − subpopulation showed superior adhesion efficiency compared to CD105 + cells. Considering in vitro and in vivo assays, this study suggests that integration of a scaffold with CD105 − subpopulation at the maturation stage represents an attractive strategy for clinical use in orthopedic bioengineering.
- 31 July 2015
- Published by SAGE Publications in Stem Cells and Development
- Vol. 24 (21) , 2577-2590
Differential Expression of Adhesion-Related Proteins and MAPK Pathways Lead to Suitable Osteoblast Differentiation of Human Mesenchymal Stem Cells Subpopulations
Cellular adhesion enables communication between cells and their environment. Adhesion can be achieved throughout focal adhesions and its components influence osteoblast differentiation of human mesenchymal stem cells (hMSCs). Because cell adhesion and osteoblast differentiation are closely related, this article aimed to analyze the expression profiles of adhesion-related proteins during osteoblastic differentiation of two hMSCs subpopulations (CD105 + and CD105 − ) and propose a strategy for assembling bone grafts based on its adhesion ability. In vitro experiments of osteogenic differentiation in CD105 − cells showed superior adhesion efficiency and 2-fold increase of α-actinin expression compared with CD105 + cells at the maturation stage. Interestingly, levels of activated β1-integrin increased in CD105 − cells during the process. Additionally, the CD105 − subpopulation showed 3-fold increase of phosphorylated FAK Y397 compared to CD105 + cells. Results also indicate that ERK1/2 was activated during CD105 − bone differentiation and participation of mitogen-activated protein kinase (MAPK)-p38 in CD105 + differentiation through a focal adhesion kinase (FAK)-independent pathway. In vivo trial demonstrated that grafts containing CD105 − showed osteocytes embedded in a mineralized matrix, promoted adequate graft integration, increased host vascular infiltration, and efficient intramembranous repairing. In contrast, grafts containing CD105 + showed deficient endochondral ossification and fibrocartilaginous tissue. Based on the expression of α-actinin, FAKy, 397 and ERK1/2 activation, we define maturation stage as critical for bone graft assembling. By in vitro assays, CD105 − subpopulation showed superior adhesion efficiency compared to CD105 + cells. Considering in vitro and in vivo assays, this study suggests that integration of a scaffold with CD105 − subpopulation at the maturation stage represents an attractive strategy for clinical use in orthopedic bioengineering.